Get started Log in

INM — InMed Pharmaceuticals Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Brief: InMed Pharmaceuticals Inc - On March 4, Co Confirmed And Approved The Decision To Wind Down Baymedica's Commercial Operations - SEC Filing
06/03/2026 22:02
Advisory: Dated alerts on InMed Pharmaceuticals withdrawn
15/12/2025 15:05
Brief: Inmed Pharmaceuticals Enters Agreement To Sell 1.9 Million Shares At $2.561 Each
30/06/2025 21:36
Brief: Inmed Pharmaceuticals Inc Amends Standby Equity Purchase Agreement With Yorkville
13/06/2025 21:33
Brief: InMed’S INM-901 Demonstrates Statistically Significant Reduction In Neuroinflammation In Long-Term Preclinical Alzheimer’S Disease Study
21/01/2025 17:23
Brief: InMed Pharmaceuticals Files For Offering Of 3 Million Common Shares By Selling Stockholder
23/12/2024 22:18
Brief: InMed Pharmaceuticals Receives Nasdaq Delisting Notice, Confirms It Has Filed Appeal & Obtained Panel Hearing Date
20/09/2024 21:28
Brief: Inmed Pharmaceuticals Says On Feb 8, Board Appointed N. Netta "Neeta" Jagpal To Serve, As CFO & Corporate Secretary, Effective As Of Feb 20, 2024
09/02/2024 17:39
Brief: Inmed Pharmaceuticals Announces Launch Of Inm-089
29/11/2023 19:55
Brief: Inmed Pharmaceuticals Inc Files For Resale Of Up To 12.6 Million Shares Of Common Stock By The Selling Shareholders - SEC Filing
08/11/2023 23:16
Brief: Inmed Pharmaceuticals' Inm-901 Demonstrates Unique Pharmacological Effects In Alzheimer's Disease In Preclinical Proof-Of-Concept Studies
24/10/2023 22:06
Brief: InMed Pharmaceuticals Says On September 19, Received Written Notice From The Listing Qualifications Department Staff Of The Nasdaq Capital Market
25/09/2023 11:12
Brief: Inmed Provides Update On Baymedica Rare Cannabinoid Business
20/07/2023 19:22
Brief: InMed Reports Second Quarter Fiscal 2023 Financial Results
17/02/2023 23:23
Brief: InMed Pharma Says Unable To File Financial Statements For Three Months Ended Dec 31, 2022 In Timely Manner
10/02/2023 02:49
Brief: InMed Provides Business Update And Milestones For 2023
10/01/2023 12:33
Brief: Inmed Says Jonathan Tegge Will Assume Role Of Interim Chief Financial Officer Effective December 12
12/12/2022 23:50
Brief: InMed Pharmaceuticals Files Prospectus Relates To Offer, Resale By Selling Shareholders Of Up To 5.09 Mln Of Common Shares
07/12/2022 22:08
Brief: InMed Pharmaceuticals Announces Closing Of $6 Mln Private Placement Priced At A Premium To Market
21/11/2022 22:25
Brief: InMed Pharmaceuticals Announces $6 Million Private Placement Priced At A Premium To Market
18/11/2022 13:06